Key Takeaways
- RKLB shares have plummeted 57% from their $151 record high, now trading at $82.83
- Wall Street maintains a “Moderate Buy” consensus with a $110.29 average price target
- First quarter 2026 revenue reached $200.35 million, representing 63.4% year-over-year growth
- The company landed approximately $663 million in recent U.S. Space Force agreements
- Company insiders have divested $362.8 million in shares during the last three months
Rocket Lab (RKLB) shares kicked off Monday’s trading session at $82.83, marking a steep 57% decline from the company’s $151 all-time high reached in June. Despite this significant pullback, analysts remain optimistic. The average price target across Wall Street sits at $110.29, suggesting potential upside of approximately 49% from present levels.
Street sentiment leans toward “Moderate Buy,” supported by three Strong Buy recommendations, thirteen Buy calls, five Hold positions, and a single Sell rating. Morgan Stanley maintained its “Overweight” stance in July, while New Street Research established a $150 target back in May.
First quarter 2026 results showed revenue of $200.35 million, climbing 63.4% compared to the prior year and surpassing Wall Street’s $189.65 million forecast. The company delivered an expected loss of $0.07 per share, matching analyst projections.
The order book provides encouraging signals. Rocket Lab signed 31 launch agreements during Q1 alone, exceeding its total for the entire 2025 calendar year. The overall backlog expanded to $2.2 billion, representing 108% growth year over year.
Adjusted EBITDA loss improved to $11.8 million, significantly better than the $26 million loss Wall Street anticipated. Following these results, no fewer than seven analysts boosted their price objectives.
Major Space Force Wins Boost Outlook
Recent contract announcements have drawn considerable attention. Rocket Lab landed a $397 million agreement with the U.S. Space Force for development, launch, and operation of sophisticated flat satellite technology utilizing its forthcoming Neutron launch vehicle. An additional $266 million Space Force deal encompasses 12 suborbital missions plus up to six optional launches, with initial deployment scheduled before year-end.
Combined, these Space Force commitments total roughly $663 million. The Neutron rocket, essential to executing the larger agreement, remains in development and has not yet conducted a test flight.
The company also successfully completed its 92nd Electron launch and 13th mission of 2026, delivering a satellite for returning customer iQPS.
Caution Flags Still Wave
Profitability remains elusive. The company reported a $45 million net loss during Q1, with analysts forecasting a full-year loss of $0.26 per share. The current price-to-sales multiple stands at 53, substantially higher than the technology sector’s typical ratio of approximately 7.
Insider transaction activity merits attention. During the previous three months, company insiders have liquidated 3.85 million shares valued at roughly $362.8 million. SVP Arjun Kampani offloaded 88,000 shares in June at an average of $107.98. A portion of these sales were attributed to tax liabilities from equity compensation vesting.
Institutional ownership accounts for 71.78% of outstanding shares. PensionDanmark expanded its position by 224.2% during Q2, purchasing 28,358 additional shares for a total holding of 41,008 shares valued near $4.17 million.
With a beta of 2.60, the stock demonstrates high volatility. Its 52-week trading range spans from $37.57 to $151.00.
Rocket Lab releases Q2 financial results following Monday’s market close on August 10. Key focus areas include revenue trajectory, Neutron development progress, and management’s outlook on achieving profitability.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
